arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Rani Therapeutics Holdings, Inc.

RANI

$0.77 0.00 (-0.42%) at close

25 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Rani Therapeutics Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $144.1M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -17.8% ↗

FCF / Share $-0.05 ↘

Trailing P/E —

Price / Book 3.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

25-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.71M

— 0.0% —

Net Income Profit after all expenses

$-7.39M

↓ -10.4% —

Operating Margin Operating profit as % of sales

-488.2%

↓ -82.1% —

FCF / Share Free cash flow per share

$-0.05

↓ -33.8% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Revenue Growth YoY (%)	—	893.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11063%)	42.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+427%)	—	—	—	—	—	—	—	—	—	—	—	—	—	N/M	—	N/M	N/M	3168.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+39504%)	—	—	—	—
EPS Growth YoY (%)	77.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	81.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	24.1% Good Good Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	87.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	19.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	-718.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-10.4% Weak ↓ Weak Declining Year-over-year change in net income	3.2% Caution ↑ Caution Improving Year-over-year change in net income	-15.2% Weak ↓ Weak Declining Year-over-year change in net income	20.2% Good ↑ Good Improving Year-over-year change in net income	1.7% Caution ↑ Caution Improving Year-over-year change in net income	2.9% Caution ↓ Caution Declining Year-over-year change in net income	-26.0% Weak ↓ Weak Declining Year-over-year change in net income	26.2% Excellent ↑ Excellent Improving Year-over-year change in net income	26.9% Excellent ↑ Excellent Improving Year-over-year change in net income	10.6% Fair ↑ Fair Improving Year-over-year change in net income	19.2% Good ↑ Good Improving Year-over-year change in net income	-15.6% Weak ↑ Weak Improving Year-over-year change in net income	-22.0% Weak ↑ Weak Improving Year-over-year change in net income	-34.5% Weak ↑ Weak Improving Year-over-year change in net income	-69.3% Weak → Weak Stable Year-over-year change in net income	-153.2% Weak ↓ Weak Declining Year-over-year change in net income	-36.2% Weak ↓ Weak Declining Year-over-year change in net income	-11.2% Weak ↓ Weak Declining Year-over-year change in net income	—	41.3% Excellent Excellent Year-over-year change in net income	-4.6% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	—	85.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	32.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	26.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-2.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	17.7% Excellent Excellent Compound annual revenue growth over 5 years	47.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Operating Margin (%) (%)	—	-488.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3355%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-268.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1888%)	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-432.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3706%)	-411.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3531%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-285.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2479%)	—	—	—	—
FCF Margin (%) (%)	—	-381.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	20.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.13x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.26x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.78x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	1.48x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.73x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	1.54x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	2.26x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	-0.13x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Return on Invested Capital (%)	-17.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-97.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-69.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-101.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-30.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-33.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-54.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	4.5% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-14.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-71.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-62.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-28.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-6.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-18.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-24.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-31.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-308%)	68.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+359%)	120.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+700%)	237.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1485%)	—	-217.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1549%)	-240.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1700%)	-101.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-774%)	-55.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-468%)	-52.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-449%)	-38.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-357%)	-27.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-23.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-18.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-15.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-11.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-10.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-6.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Debt to Equity (x)	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-1.75x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-392%)	-3.14x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-623%)	-6.95x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1259%)	4.83x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+704%)	9.21x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1436%)	10.58x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1664%)	4.06x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+576%)	1.90x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+217%)	1.71x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+185%)	1.25x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+108%)	0.98x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+63%)	0.79x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+32%)	0.36x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-41%)	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	-0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-104%)	—	—
Interest Coverage (x)	-1103.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-94.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.01x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.98x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-12.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.57x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	-46.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-13362.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-252.55x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-31.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-27.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-85.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-44.17x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1695.00x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-4.87M	$-9.64M	$-18.62M	$9.61M	$7.28M	$11.14M	$5.85M	$24.47M	$25.49M	$23.12M	$18.62M	$25.03M	$22.45M	$11.02M	$2.14M	$-12.22M	$-97.18M	$-107.84M	$-117.45M	$-129.74M	$-69.31M	—	$-70.65M	—	—
Debt / EBITDA (x)	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.89x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.67x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.77x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.64x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.44x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.40x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.14x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.82x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.68x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.64x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.82x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.68x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.49x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Revenue per Share (USD)	$0.01	$0.01	—	$0.00	$0.00	$0.01	—	—	—	—	—	—	—	—	—	$0.00	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.04	$-0.04	$0.05	$-0.12	$-0.18	$-0.22	$-0.27	$-0.24	$-0.26	$-0.29	$-0.27	$0.36	$0.37	$0.33	$-2.21	$-0.33	$0.31	—	$-0.27	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.05	$-0.04	—	$-0.11	—	$-0.25	—	—	—	$-0.36	—	—	—	$-0.49	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.21	$0.16	—	$-0.17	$-0.15	$-0.09	—	$0.11	$0.11	$0.28	—	$0.69	$0.95	$1.22	—	$1.72	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.21	$0.16	—	$-0.17	$-0.15	$-0.09	—	$0.11	$0.11	$0.28	—	$0.69	$0.95	$1.22	—	$1.72	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	187.17M	180.00M	—	46.44M	36.54M	33.44M	—	28.84M	26.32M	26.03M	—	25.55M	25.34M	25.24M	—	24.47M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Working Capital (USD)	$45.88M	$33.24M	$40.65M	$-14.19M	$-9.55M	$-2.35M	$9.85M	$12.16M	$15.45M	$28.02M	$42.86M	$55.88M	$70.64M	$83.89M	$96.11M	$93.53M	$92.64M	$105.10M	$116.95M	$127.11M	$60.12M	—	$69.64M	—	—
LT Debt (USD)	—	—	$0.00	$13.75M	$17.50M	$21.25M	$9.61M	$28.75M	$30.00M	$30.00M	$24.48M	$30.00M	$30.00M	$30.00M	$29.15M	$15.00M	—	—	$0.00	$0.00	$0.00	—	$2.41M	—	—
Total Equity (USD)	$39.23M	$28.41M	$33.01M	$-7.86M	$-5.58M	$-3.06M	$1.99M	$3.12M	$2.83M	$7.40M	$12.87M	$17.55M	$24.09M	$30.72M	$36.85M	$42.19M	$47.81M	$53.38M	$47.41M	$51.37M	—	—	$-113.34M	—	—

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗
Sales/Revenue/Turnover (USD)	$1.71M	$1.71M	$1.46M	$0.00	$0.00	$172.00K	$1.03M	—	—	—	—	—	—	—	—	$0.00	$0.00	—	$0.00	$0.00	$1.96M	$756.00K	$210.00K	$108.00K	$60.00K
Depreciation Expense (USD)	$200.00K	$200.00K	—	—	—	—	—	—	—	—	—	—	—	—	$126.00K	$141.00K	$122.00K	$111.00K	$116.00K	$120.00K	—	$136.00K	—	$144.00K	—
Net Income, GAAP (USD)	$-7.39M	$-7.03M	$-10.30M	$-5.41M	$-6.69M	$-7.26M	$-8.95M	$-6.78M	$-6.80M	$-7.48M	$-7.10M	$-9.20M	$-9.30M	$-8.37M	$-8.79M	$-7.96M	$-7.62M	$-6.22M	$-5.19M	$-3.14M	$-5.60M	$-5.60M	—	$-5.35M	$-5.35M
Operating Cash Flow (USD)	$-9.03M	$-6.50M	$294.00K	$-5.06M	—	$-8.15M	$-8.65M	—	—	$-9.40M	$-12.48M	—	—	$-12.15M	$-14.63M	—	—	$-9.36M	$-11.45M	—	—	$-4.05M	$-6.70M	$670.00K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 25 quarters

Rani Therapeutics Holdings, Inc.

Analytical Summary

25-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RANI with peers